Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Zachary J. Brown

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8347-9197; OpenAlex author ID A5068478064. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 3 papers · 2022: 5 papers · 2023: 1 paper · 2024: 2 papers

Papers 11

  1. Letter to the editor: Understanding surgical attrition for "resectable" pancreatic cancer. Co-author DOI 10.1016/j.hpb.2024.01.004↗
  2. Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma. Co-author DOI 10.23736/s2724-5691.23.10150-x↗
  3. Evaluating the Quality of Online Information Regarding Neoadjuvant Therapy for Pancreatic Cancer. Co-author DOI 10.1007/s12029-022-00879-z↗
  4. Impact of care fragmentation on the outcomes of patients receiving neoadjuvant and adjuvant therapy for pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.26706↗
  5. Routine neoadjuvant chemotherapy for all patients with resectable pancreatic ductal adenocarcinoma? A review of the evidence. Co-author DOI 10.1016/j.coph.2022.102305↗
  6. Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies. Co-author DOI 10.1016/j.suronc.2022.101803↗
  7. Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis. Co-author DOI 10.1093/bjs/znac354↗
  8. Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study. First author DOI 10.4251/wjgo.v14.i6.1175↗
  9. Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jso.26384↗
  10. Surgery for pancreatic cancer: recent progress and future directions. Co-author DOI 10.21037/hbsn-21-18↗
  11. Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care. First author DOI 10.3748/wjg.v27.i27.4383↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jordan M. Cloyd · 10 shared papers, 2021–2024 · strength 2.53
  2. Aslam M. Ejaz · 5 shared papers, 2021–2023 · strength 0.89
  3. Timothy Michael Pawlik · 5 shared papers, 2022–2023 · strength 0.88
  4. Lena Stevens · 2 shared papers, 2022–2023 · strength 0.38
  5. Mary E. Dillhoff · 2 shared papers, 2021–2022 · strength 0.33
  6. Samantha M. Ruff · 1 shared paper, 2022 · strength 0.26
  7. Ahmad B. Hamad · 1 shared paper, 2021 · strength 0.17
  8. Daniel Brock Hewitt · 1 shared paper, 2022 · strength 0.16
  9. Daniel Osei‐Bordom · 1 shared paper, 2022 · strength 0.16
  10. Heena P. Santry · 1 shared paper, 2022 · strength 0.16
  11. Allan Tsung · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.